Now at SIIM 2026 · Startup Kiosk 3 · June 10–12

INTDose · Independent Dose Verification Platform

Fast and Accurate Independent Dose Verification

FDA 510(k) K213137, cleared 2022. A TPS-neutral Monte Carlo recalculation that shares no engine, beam data, or geometry with your planning system. Under 5 minutes per plan.

Independent Monte Carlo dose distribution overlaid on a CT slice

See it in action

INTDose walkthrough

A 90-second walkthrough of the typical clinical workflow — DICOM import through gamma analysis and PDF report.

What it catches

The errors a TPS won't flag

An independent engine catches what a self-consistent one can't. The classes of failure INTDose is positioned to find:

Monitor-unit miscalc

MU errors that pass TPS sanity checks but deliver the wrong dose at the machine.

Contour vs delivery mismatch

When the planning contour set does not match what is delivered — geometry drift between TPS export and treatment.

Compounding monthly drift

Small machine-output variations that accumulate over a course of treatment and only show up across many plans.

Wrong modality / energy

Plans tagged with the wrong photon energy or modality flag — a TPS will compute happily on the wrong assumption.

MLC leaf-position issues

Leaf-position errors below the TPS tolerance threshold that an independent geometry pass surfaces.

Geometric handling differences

Where the TPS and the linac disagree on coordinate frames or beam geometry — caught by recomputing from first principles.

How it works

DICOM-RT in. PDF report out. Under 5 minutes

  1. 01

    Import DICOM-RT

    Plan, CT, RT structure, and RT dose — DICOM push from PACS, direct upload, or Varian API. No manual entry.

  2. 02

    Recompute, parameter-independent

    Full Monte Carlo on the original CT with the planned beams and an independent machine model. Shares no engine, beam data, or geometry with the TPS.

  3. 03

    Gamma + DVH compare

    3-D gamma index at clinical tolerances (3%/2mm, 3%/3mm). Per-structure DVH overlay shows where doses diverge.

  4. 04

    Archive a PDF report

    Mean-dose comparison (global + OAR-stratified), gamma map, 1-D and 2-D dose profiles. Filed alongside the planning record.

What makes INTDose different

Three things to trust

A secondary-check tool earns its place by answering three questions: is it actually independent, is the number accurate, and does it slow your day down?

A second check that is actually independent

  • Different engine, different beam data, different geometry handling than your TPS.
  • The errors a self-consistent TPS can't catch on itself — MU miscalculations, MLC drift, modality mistags, geometric mismatches — INTDose surfaces.
  • 3-D gamma index at clinical tolerances (3%/2mm, 3%/3mm) and per-structure DVH overlays show where doses diverge.
INTDose DVH overlay showing TPS dose (solid) vs INTDose Monte Carlo recomputation (dotted) for 16+ structures

Monte Carlo, validated to a number you can stand behind

  • Full Monte Carlo recalculation on in-house virtual source models — the gold standard for dose deposition, computed from first principles.
  • Depth-dose and off-axis profiles validated within 1% of Varian Gold beam data. Per-machine commissioning (jaw, MLC, latency, HU-to-density) keeps the simulation matched to measured output.
  • FDA 510(k) K213137 cleared 2022. AAPM TG-119 and TG-244 validated. Recommended by TG-114 and TG-219 as part of a comprehensive QA program.
INTDose Monte Carlo dose-verification report with DVH and isodose overlay

Runs alongside your clinical day, not in front of it

  • Under 5 minutes per plan on typical clinical hardware. Pre-treatment QA without disrupting the schedule.
  • Installed locally as a web service. DICOM push, direct upload, or Varian API — no manual entry.
  • Automatic task execution polls for new studies and runs verification without operator action. PDF report files alongside the planning record.
INTDose study list — automatic task execution polling for new studies and verifying them in the background

Evidence

Standards, validation, and publications

Standards & validation

FDA 510(k)

K213137

Cleared 2022. Software for radiation treatment plan QA. See compliance →

AAPM standards alignment

  • TG-114 & TG-219 — recommended secondary-check program for MU and IMRT/VMAT
  • TG-119 — IMRT commissioning validated
  • TG-244 — Monte Carlo dose-engine validated

Beam model accuracy

In-house virtual source models describe the radiation field at each machine's treatment head. Depth-dose and off-axis profiles measured within 1% of Varian Gold beam data across the commissioned set.

Peer-reviewed publications

The Monte Carlo engine and virtual-source models behind INTDose are published across more than a decade of medical-physics literature.

See all publications →

Compatibility & workflow

Where INTDose fits

On-premise. TPS-neutral. Integrates into the workflow you already run.

Treatment machines

  • Varian conventional linacs
  • Varian Halcyon
  • TomoTherapy

Treatment planning systems

  • Varian Eclipse
  • Philips Pinnacle

Modalities & techniques

  • Photons
  • 3-D conformal (3DCRT)
  • IMRT
  • VMAT

Integration

  • DICOM listener (push from PACS)
  • Web upload from disk
  • Varian API integration
  • Automatic task execution (poll new studies)

Independent QA on every plan